-
-
-
-
-
-
-
MyoKardia Reports Second Quarter 2020 Financial Results
-
-
-
-
-
-
-
MyoKardia Reports Second Quarter 2019 Financial Results
-
-
-
-
-
-
-
MyoKardia (MYOK) Re-acquires Global Rights to Mavacamten and MYK-491 Programs from Sanofi (SNY)
-
-
-
-
-
-
-
MyoKardia Reports First Quarter 2018 Financial Results
-
-
-
-
-
-
-
MyoKardia Reports Third Quarter 2017 Financial Results and Operational Progress
-
-
-
-
-
-
-
MyoKardia to Announce First Quarter 2017 Financial Results and Host Conference Call on Tuesday, May 9, 2017
-
-
-
-
-
-
-
MyoKardia Reports First Quarter 2016 Financial Results and Operational Progress
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

